Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Jan 2020
Historique:
received: 03 01 2020
revised: 28 01 2020
accepted: 29 01 2020
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 18 11 2020
Statut: epublish

Résumé

Proton pump inhibitor use is associated with an increased risk of gastric cancer, which may be mediated by hypergastrinemia. Spasmolytic polypeptide-expression metaplasia (SPEM) has been proposed as a precursor of gastric cancer. We have examined the effects of the gastrin receptor antagonist netazepide (NTZ) or vehicle on the gastric corpus mucosa of H

Identifiants

pubmed: 32023822
pii: ijms21030927
doi: 10.3390/ijms21030927
pmc: PMC7037105
pii:
doi:

Substances chimiques

Benzodiazepinones 0
Intercellular Signaling Peptides and Proteins 0
Phenylurea Compounds 0
spasmolytic polypeptide 0
H(+)-K(+)-Exchanging ATPase EC 3.6.3.10
YF 476 HOU4I0G29C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Norges Teknisk-Naturvitenskapelige Universitet
ID : none
Organisme : Nowegian Gastroenterologists Association
ID : none

Références

Scand J Gastroenterol. 1985 Jun;20(5):569-76
pubmed: 2992067
Am J Physiol Gastrointest Liver Physiol. 2001 Dec;281(6):G1502-11
pubmed: 11705756
Gut. 2019 Sep;68(9):1545-1575
pubmed: 31278206
Am J Gastroenterol. 1997 Oct;92(10):1858-60
pubmed: 9382052
Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):625-647
pubmed: 27766298
Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G362-75
pubmed: 15647607
Scand J Gastroenterol. 1992 Jun;27(6):479-82
pubmed: 1352909
Am J Pathol. 1993 Apr;142(4):1173-85
pubmed: 8097370
Cancer Sci. 2013 Oct;104(10):1323-9
pubmed: 23848514
N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
Gut. 2015 Apr;64(4):544-53
pubmed: 24951258
Therap Adv Gastroenterol. 2016 Sep;9(5):671-8
pubmed: 27582879
Aliment Pharmacol Ther. 2012 Jul;36(2):181-9
pubmed: 22607579
Gastroenterology. 2010 Jul;139(1):213-25.e3
pubmed: 20398667
PLoS One. 2013 Oct 01;8(10):e76462
pubmed: 24098507
Am J Physiol Gastrointest Liver Physiol. 2010 Dec;299(6):G1241-51
pubmed: 20813912
J Pathol. 2019 Jul;248(3):316-325
pubmed: 30746716
Arch Pathol Lab Med. 2004 Jul;128(7):765-70
pubmed: 15214826
J Pathol. 2018 Jun;245(2):132-137
pubmed: 29508389
Gastroenterology. 2010 Jun;138(7):2207-10, 2210.e1
pubmed: 20450866
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Cell. 1985 Jul;41(3):1017-28
pubmed: 3924408
Gut. 2013 Sep;62(9):1270-9
pubmed: 22773549
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Regul Pept. 2010 Jun 8;162(1-3):52-60
pubmed: 20144901
Regul Pept. 1983 Jul;6(3):263-80
pubmed: 6622754
APMIS. 2015 Jun;123(6):509-14
pubmed: 25939315
Aliment Pharmacol Ther. 1997 Feb;11(1):113-20
pubmed: 9042983
Biochim Biophys Acta. 2006 Aug;1766(1):23-41
pubmed: 16490321
Scand J Gastroenterol. 2001 Nov;36(11):1128-33
pubmed: 11686210
Cancer Epidemiol. 2019 Oct;62:101585
pubmed: 31445426
Cell Mol Gastroenterol Hepatol. 2016 Nov 16;3(1):11-26
pubmed: 28174755
Int Rev Cytol. 1969;26:235-302
pubmed: 4899604
Gut. 2018 Oct;67(10):1908-1910
pubmed: 29273641
Scand J Gastroenterol. 2010 Sep;45(9):1042-7
pubmed: 20476858
Int J Epidemiol. 2017 Jun 1;46(3):914-923
pubmed: 28369403
Rev Esp Enferm Dig. 2016 Apr;108(4):207-24
pubmed: 27034082
Gastroenterology. 2010 Dec;139(6):2028-2037.e9
pubmed: 20854822
J Clin Pathol. 1989 Apr;42(4):371-7
pubmed: 2715350
Endoscopy. 2019 Apr;51(4):365-388
pubmed: 30841008
Nature. 1978 Dec 21-28;276(5690):834-6
pubmed: 31568
Carcinogenesis. 2003 Dec;24(12):1887-96
pubmed: 12949047
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1345-1352
pubmed: 27682220
Exp Cell Res. 2011 Nov 15;317(19):2759-64
pubmed: 21907708
J Biomed Biotechnol. 2011;2011:975479
pubmed: 21127707
Int J Mol Sci. 2018 Dec 10;19(12):
pubmed: 30544709
Gastroenterology. 2010 Dec;139(6):2038-49
pubmed: 20816838
Gastroenterology. 1990 Jul;99(1):17-26
pubmed: 2344924
Gut. 1991 Jun;32(6):698-701
pubmed: 1711995
Gastroenterology. 2005 Jun;128(7):1965-83
pubmed: 15940630
Molecules. 2019 Aug 08;24(16):
pubmed: 31398865
Am J Physiol. 1997 May;272(5 Pt 1):G1209-20
pubmed: 9176232
Dig Dis Sci. 2009 Aug;54(8):1625-35
pubmed: 19507031
Infect Immun. 2008 Feb;76(2):639-45
pubmed: 18025100
Acta Med Scand. 1979;206(4):315-8
pubmed: 506804
Gastroenterology. 2008 Feb;134(2):511-22
pubmed: 18242217
Peptides. 1997;18(5):663-72
pubmed: 9213359
J Endocrinol. 2016 Aug;230(2):251-62
pubmed: 27325243
Curr Opin Gastroenterol. 2018 Nov;34(6):458-464
pubmed: 30138135
Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1211-20
pubmed: 19359424
Cell Mol Gastroenterol Hepatol. 2016 Sep;2(5):546-559
pubmed: 27642625
Aliment Pharmacol Ther. 2012 Dec;36(11-12):1067-75
pubmed: 23072686
Gut. 2018 Jan;67(1):28-35
pubmed: 29089382
PLoS One. 2017 Sep 13;12(9):e0184514
pubmed: 28902909
Cancer Cell. 2015 Dec 14;28(6):800-814
pubmed: 26585400
Cell Mol Gastroenterol Hepatol. 2019;7(1):246-250.e1
pubmed: 30585162
BMJ Open. 2017 Oct 30;7(10):e017739
pubmed: 29084798
Aliment Pharmacol Ther. 2006 Nov 1;24(9):1341-8
pubmed: 17059515
Am J Surg Pathol. 1996 Oct;20(10):1161-81
pubmed: 8827022
N Engl J Med. 1996 Jul 25;335(4):242-9
pubmed: 8657240
Biochem Soc Trans. 1992 Aug;20(3):637-42
pubmed: 1426604
Cancer. 1982 Dec 1;50(11 Suppl):2554-65
pubmed: 7139550
Gastroenterology. 1999 Sep;117(3):605-18
pubmed: 10464136

Auteurs

Kristin Matre Aasarød (KM)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Department of Gastroenterology and Hepatology, Clinic of Medicine, St Olav's University Hospital, 7491 Trondheim, Norway.

Helge Lyder Waldum (HL)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Astrid Kamilla Stunes (AK)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Arne Kristian Sandvik (AK)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Department of Gastroenterology and Hepatology, Clinic of Medicine, St Olav's University Hospital, 7491 Trondheim, Norway.
Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Arnar Flatberg (A)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Patricia Mjønes (P)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Department of Pathology, Clinic of Laboratory Medicine, St Olav´s University Hospital, 7491 Trondheim, Norway.

Unni Syversen (U)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Department of Endocrinology, Clinic of medicine, St. Olav´s University Hospital, 7491 Trondheim, Norway.

Ingunn Bakke (I)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Clinic of Medicine, St. Olav's University Hospital, 7491 Trondheim, Norway.

Reidar Fossmark (R)

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Department of Gastroenterology and Hepatology, Clinic of Medicine, St Olav's University Hospital, 7491 Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH